CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: imipramine
Accession: CHEBI:47499
browse the term
Definition: A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Synonyms: exact_synonym: 3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine
related_synonym: 10,11-dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-propanamine; 3-(5H-DIBENZO[B,F]AZEPIN-5-YL)-N,N-DIMETHYLPROPAN-1-AMINE; 5-[3-(dimethylamino)propyl]-10,11-dihydro-5H-dibenz[b,f]azepine; Antideprin; Formula=C19H24N2; Imipramin; InChI=1S/C19H24N2/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h3-6,8-11H,7,12-15H2,1-2H3; InChIKey=BCGWQEUPMDMJNV-UHFFFAOYSA-N; Irmin; Melipramine; N-(gamma-dimethylaminopropyl)iminodibenzyl; SMILES=CN(C)CCCN1c2ccccc2CCc2ccccc12; imipraminum; imizine
alt_id: CHEBI:47498; CHEBI:5881
xref: Beilstein:256892; CAS:50-49-7; DrugBank:DB00458; Drug_Central:1427; Gmelin:1572523; HMDB:HMDB0001848; KEGG:C07049; KEGG:D08070; LINCS:LSM-2852
xref_mesh: MESH:D007099
xref: PDBeChem:IXX; PMID:20825390; Patent:US2554736; Reaxys:256892; Wikipedia:Imipramine
G
AADAT
aminoadipate aminotransferase
affects expression
ISO
Imipramine affects the expression of AADAT mRNA
CTD
PMID:18355885
NCBI chr 4:170,060,222...170,094,292
Ensembl chr 4:170,060,222...170,091,699
G
ABCB1
ATP binding cassette subfamily B member 1
affects expression
ISO
Imipramine affects the expression of ABCB1 mRNA
CTD
PMID:18355885
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
G
ACE2
angiotensin converting enzyme 2
decreases expression
EXP
Imipramine results in decreased expression of ACE2 mRNA
CTD
PMID:32808185
NCBI chr X:15,518,197...15,607,211
Ensembl chr X:15,494,566...15,607,236
G
ACHE
acetylcholinesterase (Yt blood group)
multiple interactions increases activity decreases activity
EXP ISO
Imipramine inhibits the reaction [asoxime chloride inhibits the reaction [cyclohexyl methylphosphonofluoridate results in decreased activity of ACHE protein]]; Imipramine inhibits the reaction [asoxime chloride inhibits the reaction [Sarin results in decreased activity of ACHE protein]]; Imipramine inhibits the reaction [Obidoxime Chloride metabolite results in decreased activity of ACHE protein]; Imipramine promotes the reaction [Obidoxime Chloride inhibits the reaction [Sarin results in decreased activity of ACHE protein]] Imipramine results in increased activity of ACHE protein Imipramine results in decreased activity of ACHE protein
CTD
PMID:25522658 PMID:29614332
NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
G
ADRB1
adrenoceptor beta 1
multiple interactions decreases activity
ISO
[Imipramine co-treated with Idazoxan] results in decreased activity of ADRB1 protein; [Imipramine co-treated with Yohimbine] results in decreased activity of ADRB1 protein Imipramine results in decreased activity of ADRB1 protein
CTD
PMID:2868116
NCBI chr10:114,043,866...114,046,904
Ensembl chr10:114,043,866...114,046,904
G
ADRB2
adrenoceptor beta 2
decreases expression
EXP
Imipramine results in decreased expression of ADRB2 protein
CTD
PMID:10618463
NCBI chr 5:148,826,611...148,828,623
Ensembl chr 5:148,826,611...148,828,623
G
ALB
albumin
affects binding
EXP
Imipramine binds to ALB protein
CTD
PMID:20956006
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
G
ALDH1A1
aldehyde dehydrogenase 1 family member A1
affects expression
ISO
Imipramine affects the expression of ALDH1A1 mRNA
CTD
PMID:18355885
NCBI chr 9:72,900,671...72,953,053
Ensembl chr 9:72,900,671...73,080,442
G
AP2M1
adaptor related protein complex 2 subunit mu 1
multiple interactions
ISO
Imipramine inhibits the reaction [NTRK2 protein binds to AP2M1 protein]
CTD
PMID:31631060
NCBI chr 3:184,174,855...184,184,091
Ensembl chr 3:184,174,689...184,184,214
G
APOA4
apolipoprotein A4
affects expression
ISO
Imipramine affects the expression of APOA4 mRNA
CTD
PMID:18355885
NCBI chr11:116,820,700...116,823,304
Ensembl chr11:116,820,700...116,823,304
G
ARG1
arginase 1
multiple interactions
ISO
Imipramine affects the reaction [caryophyllene inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased expression of ARG1 protein]]
CTD
PMID:30620895
NCBI chr 6:131,573,226...131,584,329
Ensembl chr 6:131,470,832...131,584,332
G
ASAH1
N-acylsphingosine amidohydrolase 1
increases expression
EXP
Imipramine results in increased expression of ASAH1 mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr 8:18,055,992...18,084,961
Ensembl chr 8:18,055,992...18,084,998
G
ASNS
asparagine synthetase (glutamine-hydrolyzing)
increases expression
EXP
Imipramine results in increased expression of ASNS mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr 7:97,851,677...97,928,441
Ensembl chr 7:97,851,677...97,872,542
G
BDNF
brain derived neurotrophic factor
increases expression multiple interactions affects expression
ISO
Imipramine results in increased expression of BDNF mRNA Rolipram promotes the reaction [Imipramine results in increased expression of BDNF mRNA] Imipramine affects the expression of BDNF protein
CTD
PMID:8601816 PMID:15157811 PMID:17617388 PMID:17950272
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
G
BHMT
betaine--homocysteine S-methyltransferase
affects expression
ISO
Imipramine affects the expression of BHMT mRNA
CTD
PMID:18355885
NCBI chr 5:79,111,809...79,132,288
Ensembl chr 5:79,111,809...79,132,288
G
CASP3
caspase 3
multiple interactions increases activity
EXP
Imipramine results in increased cleavage of and results in increased activity of CASP3 protein; Palmitic Acid promotes the reaction [Imipramine results in increased activity of CASP3 protein]
CTD
PMID:10487422 PMID:22700542
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CASP7
caspase 7
increases activity multiple interactions
EXP
Imipramine results in increased activity of CASP7 protein Palmitic Acid promotes the reaction [Imipramine results in increased activity of CASP7 protein]
CTD
PMID:22700542
NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907
G
CASP8
caspase 8
multiple interactions
ISO
Imipramine inhibits the reaction [lead acetate results in increased activity of CASP8 protein]
CTD
PMID:22033380
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
G
CAT
catalase
affects activity multiple interactions
ISO
Imipramine affects the activity of CAT protein Imipramine inhibits the reaction [Streptozocin results in increased activity of CAT protein]
CTD
PMID:19798453 PMID:34352274
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CDKN2C
cyclin dependent kinase inhibitor 2C
affects expression
ISO
Imipramine affects the expression of CDKN2C mRNA
CTD
PMID:18355885
NCBI chr 1:50,968,706...50,974,634
Ensembl chr 1:50,960,745...50,974,634
G
CES2
carboxylesterase 2
affects expression
ISO
Imipramine affects the expression of CES2 mRNA
CTD
PMID:18355885
NCBI chr16:66,934,471...66,945,096
Ensembl chr16:66,934,444...66,945,096
G
CMTM6
CKLF like MARVEL transmembrane domain containing 6
affects expression
ISO
Imipramine affects the expression of CMTM6 mRNA
CTD
PMID:18355885
NCBI chr 3:32,481,312...32,502,852
Ensembl chr 3:32,481,312...32,502,852
G
CNR1
cannabinoid receptor 1
decreases expression
ISO
Imipramine results in decreased expression of CNR1 protein
CTD
PMID:28866072
NCBI chr 6:88,139,864...88,167,349
Ensembl chr 6:88,139,864...88,166,347
G
CNR2
cannabinoid receptor 2
increases expression
ISO
Imipramine results in increased expression of CNR2 protein
CTD
PMID:28866072
NCBI chr 1:23,870,515...23,913,362
Ensembl chr 1:23,870,515...23,913,362
G
CPPED1
calcineurin like phosphoesterase domain containing 1
affects expression
ISO
Imipramine affects the expression of CPPED1 mRNA
CTD
PMID:18355885
NCBI chr16:12,659,799...12,803,887
Ensembl chr16:12,659,799...12,803,887
G
CREB1
cAMP responsive element binding protein 1
increases expression increases phosphorylation multiple interactions
ISO
Imipramine results in increased expression of CREB1 mRNA Imipramine results in increased phosphorylation of CREB1 protein Rolipram promotes the reaction [Imipramine results in increased expression of CREB1 mRNA]
CTD
PMID:8601816 PMID:22396798
NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988
G
CREM
cAMP responsive element modulator
affects expression
ISO
Imipramine affects the expression of CREM mRNA
CTD
PMID:18355885
NCBI chr10:35,126,846...35,212,958
Ensembl chr10:35,126,791...35,212,958
G
CRH
corticotropin releasing hormone
affects activity
ISO
Imipramine affects the activity of CRH protein
CTD
PMID:2553044
NCBI chr 8:66,176,376...66,178,464
Ensembl chr 8:66,176,376...66,178,464
G
CYP1A2
cytochrome P450 family 1 subfamily A member 2
affects metabolic processing increases metabolic processing multiple interactions
EXP
CYP1A2 protein affects the metabolism of Imipramine CYP1A2 protein results in increased metabolism of Imipramine CYP1A2 protein results in decreased methylation of and results in increased activity of Imipramine; Imipramine inhibits the reaction [resveratrol results in decreased activity of CYP1A2 protein]; Organophosphorus Compounds inhibits the reaction [CYP1A2 protein results in decreased methylation of and results in increased activity of Imipramine]
CTD
PMID:11714871 PMID:15286053 PMID:15922009
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
G
CYP2A13
cytochrome P450 family 2 subfamily A member 13
affects expression
ISO
Imipramine affects the expression of CYP2A1 mRNA
CTD
PMID:18355885
NCBI chr19:41,088,451...41,096,195
Ensembl chr19:41,088,451...41,096,195
G
CYP2C19
cytochrome P450 family 2 subfamily C member 19
affects metabolic processing multiple interactions
EXP
CYP2C19 protein affects the metabolism of Imipramine CYP2C19 protein results in decreased methylation of and results in increased activity of Imipramine; Organophosphorus Compounds inhibits the reaction [CYP2C19 protein results in decreased methylation of and results in increased activity of Imipramine]
CTD
PMID:15286053 PMID:15922009
NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547
G
CYP2D6
cytochrome P450 family 2 subfamily D member 6
affects metabolic processing
EXP
CYP2D6 protein affects the metabolism of Imipramine
CTD
PMID:15286053
NCBI chr22:42,126,499...42,130,810
Ensembl chr22:42,126,499...42,130,865
G
CYP3A4
cytochrome P450 family 3 subfamily A member 4
multiple interactions
EXP
CYP3A4 protein results in decreased methylation of and results in increased activity of Imipramine; Organophosphorus Compounds inhibits the reaction [CYP3A4 protein results in decreased methylation of and results in increased activity of Imipramine]
CTD
PMID:15922009
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
G
CYP4F12
cytochrome P450 family 4 subfamily F member 12
affects expression
ISO
Imipramine affects the expression of CYP4F2 mRNA
CTD
PMID:18355885
NCBI chr19:15,673,087...15,697,174
Ensembl chr19:15,673,018...15,697,174
G
DCAF8
DDB1 and CUL4 associated factor 8
affects expression
ISO
Imipramine affects the expression of DCAF8 mRNA
CTD
PMID:18355885
NCBI chr 1:160,215,720...160,262,549
Ensembl chr 1:160,215,715...160,262,549
G
DEPP1
DEPP autophagy regulator 1
increases expression
EXP
Imipramine results in increased expression of DEPP1 mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr10:44,976,128...44,978,809
Ensembl chr10:44,970,981...44,978,809
G
DNAJC5
DnaJ heat shock protein family (Hsp40) member C5
increases expression
EXP
Imipramine results in increased expression of DNAJC5 mRNA; Imipramine results in increased expression of DNAJC5 protein
CTD
PMID:11257428
NCBI chr20:63,895,126...63,936,011
Ensembl chr20:63,895,126...63,936,031
G
EIF4B
eukaryotic translation initiation factor 4B
affects expression
ISO
Imipramine affects the expression of EIF4B mRNA
CTD
PMID:18355885
NCBI chr12:53,006,456...53,042,215
Ensembl chr12:53,006,282...53,042,215
G
EPHX1
epoxide hydrolase 1
affects expression
ISO
Imipramine affects the expression of EPHX1 mRNA
CTD
PMID:18355885
NCBI chr 1:225,810,124...225,845,563
Ensembl chr 1:225,810,124...225,845,563
G
ERP29
endoplasmic reticulum protein 29
affects expression
ISO
Imipramine affects the expression of ERP29 mRNA
CTD
PMID:18355885
NCBI chr12:112,013,426...112,023,449
Ensembl chr12:112,013,348...112,023,449
G
FABP1
fatty acid binding protein 1
increases expression
EXP
Imipramine results in increased expression of FABP1 mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr 2:88,122,982...88,128,062
Ensembl chr 2:88,122,982...88,128,062
G
FNDC4
fibronectin type III domain containing 4
increases expression
EXP
Imipramine results in increased expression of FNDC4 mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr 2:27,491,883...27,495,200
Ensembl chr 2:27,491,883...27,495,200
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
decreases expression
ISO
Imipramine results in decreased expression of FOS mRNA
CTD
PMID:7612155
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
G
GAP43
growth associated protein 43
decreases expression
ISO
Imipramine results in decreased expression of GAP43 mRNA
CTD
PMID:17950272
NCBI chr 3:115,623,510...115,721,483
Ensembl chr 3:115,623,510...115,721,490
G
GCKR
glucokinase regulator
affects expression
ISO
Imipramine affects the expression of GCKR mRNA
CTD
PMID:18355885
NCBI chr 2:27,496,839...27,523,684
Ensembl chr 2:27,496,839...27,523,684
G
GDPD3
glycerophosphodiester phosphodiesterase domain containing 3
increases expression
EXP
Imipramine results in increased expression of GDPD3 mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr16:30,104,810...30,113,537
Ensembl chr16:30,104,810...30,113,537
G
GLS2
glutaminase 2
affects expression
ISO
Imipramine affects the expression of GLS2 mRNA
CTD
PMID:18355885
NCBI chr12:56,470,952...56,488,161
Ensembl chr12:56,470,944...56,488,414
G
GOT2
glutamic-oxaloacetic transaminase 2
affects expression
ISO
Imipramine affects the expression of GOT2 mRNA
CTD
PMID:18355885
NCBI chr16:58,707,131...58,734,316
Ensembl chr16:58,707,131...58,734,342
G
GRB14
growth factor receptor bound protein 14
affects expression
ISO
Imipramine affects the expression of GRB14 mRNA
CTD
PMID:18355885
NCBI chr 2:164,492,417...164,621,482
Ensembl chr 2:164,492,417...164,621,482
G
GRIN1
glutamate ionotropic receptor NMDA type subunit 1
decreases expression
EXP
Imipramine results in decreased expression of GRIN1 mRNA
CTD
PMID:34748853
NCBI chr 9:137,139,154...137,168,756
Ensembl chr 9:137,138,346...137,168,756
G
GSTP1
glutathione S-transferase pi 1
decreases activity
EXP
Imipramine results in decreased activity of GSTP1 protein
CTD
PMID:15094841
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
G
HAL
histidine ammonia-lyase
affects expression
ISO
Imipramine affects the expression of HAL mRNA
CTD
PMID:18355885
NCBI chr12:95,972,662...95,996,344
Ensembl chr12:95,972,662...95,996,365
G
HDAC5
histone deacetylase 5
increases expression
ISO
Imipramine results in increased expression of HDAC5 mRNA
CTD
PMID:17988634
NCBI chr17:44,076,753...44,123,641
Ensembl chr17:44,076,746...44,123,702
G
HMBS
hydroxymethylbilane synthase
decreases activity
ISO
Imipramine results in decreased activity of HMBS protein
CTD
PMID:10416826
NCBI chr11:119,084,881...119,093,549
Ensembl chr11:119,084,866...119,093,834
G
HMGB2
high mobility group box 2
affects expression
ISO
Imipramine affects the expression of HMGB2 mRNA
CTD
PMID:18355885
NCBI chr 4:173,331,376...173,334,358
Ensembl chr 4:173,331,376...173,334,432
G
HMGCS1
3-hydroxy-3-methylglutaryl-CoA synthase 1
increases expression
EXP
Imipramine results in increased expression of HMGCS1 mRNA
CTD
PMID:16324787
NCBI chr 5:43,287,470...43,313,412
Ensembl chr 5:43,287,470...43,313,512
G
HPN
hepsin
increases expression
EXP
Imipramine results in increased expression of HPN mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr19:35,040,506...35,066,573
Ensembl chr19:35,040,506...35,066,573
G
HSF1
heat shock transcription factor 1
decreases activity
EXP
Imipramine results in decreased activity of HSF1 protein
CTD
PMID:34170685
NCBI chr 8:144,291,604...144,314,720
Ensembl chr 8:144,291,591...144,314,720
G
HSPA8
heat shock protein family A (Hsp70) member 8
increases expression
ISO
Imipramine results in increased expression of HSPA8 mRNA alternative form; Imipramine results in increased expression of HSPA8 protein alternative form
CTD
PMID:10425221
NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230
G
HTR1A
5-hydroxytryptamine receptor 1A
affects expression
ISO
Imipramine affects the expression of HTR1A mRNA
CTD
PMID:17617388
NCBI chr 5:63,957,874...63,962,445
Ensembl chr 5:63,957,874...63,962,507
G
HTR2A
5-hydroxytryptamine receptor 2A
decreases expression
ISO
Imipramine results in decreased expression of HTR2A
CTD
PMID:2553044
NCBI chr13:46,831,546...46,898,082
Ensembl chr13:46,831,546...46,897,076
G
IL10
interleukin 10
multiple interactions
ISO
Imipramine affects the reaction [caryophyllene promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL10 protein]]
CTD
PMID:30620895
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL1B
interleukin 1 beta
multiple interactions
ISO
Imipramine affects the reaction [caryophyllene inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL1B protein]]; Imipramine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL1B protein]
CTD
PMID:30620895
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL33
interleukin 33
affects expression
ISO
Imipramine affects the expression of IL33 mRNA
CTD
PMID:18355885
NCBI chr 9:6,215,149...6,257,983
Ensembl chr 9:6,215,786...6,257,983
G
INHBE
inhibin subunit beta E
increases expression
EXP
Imipramine results in increased expression of INHBE mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr12:57,455,307...57,458,025
Ensembl chr12:57,452,323...57,459,280
G
KCNH1
potassium voltage-gated channel subfamily H member 1
multiple interactions
EXP
Imipramine binds to and results in decreased activity of KCNH1 protein
CTD
PMID:18497958
NCBI chr 1:210,678,314...211,134,148
Ensembl chr 1:210,676,823...211,134,165
G
KCNH2
potassium voltage-gated channel subfamily H member 2
multiple interactions decreases activity decreases localization
EXP ISO
Imipramine binds to and results in decreased activity of KCNH2 protein; Imipramine inhibits the reaction [KCNH2 protein results in increased transport of Thallium] Imipramine results in decreased activity of KCNH2 protein Imipramine results in decreased localization of KCNH2 protein
CTD
PMID:15272206 PMID:19583963 PMID:21158687 PMID:21525004 PMID:24052561
NCBI chr 7:150,944,961...150,978,321
Ensembl chr 7:150,944,961...150,978,321
G
KCNN2
potassium calcium-activated channel subfamily N member 2
decreases activity
ISO
Imipramine results in decreased activity of KCNN2 protein
CTD
PMID:10915830
NCBI chr 5:114,055,978...114,496,496
Ensembl chr 5:114,055,926...114,496,500
G
LOX
lysyl oxidase
affects expression
ISO
Imipramine affects the expression of LOX mRNA
CTD
PMID:18355885
NCBI chr 5:122,063,195...122,078,259
Ensembl chr 5:122,063,195...122,078,413
G
LSS
lanosterol synthase
increases expression
EXP
Imipramine results in increased expression of LSS mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr21:46,188,446...46,228,774
Ensembl chr21:46,188,141...46,228,824
G
MACROH2A1
macroH2A.1 histone
affects expression
ISO
Imipramine affects the expression of MACROH2A1 mRNA
CTD
PMID:18355885
NCBI chr 5:135,334,381...135,399,887
Ensembl chr 5:135,334,381...135,399,914
G
MANBA
mannosidase beta
affects expression
ISO
Imipramine affects the expression of MANBA mRNA
CTD
PMID:18355885
NCBI chr 4:102,630,770...102,760,968
Ensembl chr 4:102,630,770...102,760,994
G
MAPK1
mitogen-activated protein kinase 1
multiple interactions
ISO
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Imipramine binds to and results in increased activity of MAPK1 protein]; Imipramine binds to and results in increased activity of MAPK1 protein
CTD
PMID:20484120
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MAPK3
mitogen-activated protein kinase 3
multiple interactions
ISO
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Imipramine binds to and results in increased activity of MAPK3 protein]; Imipramine binds to and results in increased activity of MAPK3 protein
CTD
PMID:20484120
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
MLX
MAX dimerization protein MLX
affects expression
ISO
Imipramine affects the expression of MLX mRNA
CTD
PMID:18355885
NCBI chr17:42,567,100...42,573,203
Ensembl chr17:42,567,072...42,573,239
G
MRPS18B
mitochondrial ribosomal protein S18B
affects expression
ISO
Imipramine affects the expression of MRPS18B mRNA
CTD
PMID:18355885
NCBI chr 6:30,617,840...30,626,392
Ensembl chr 6:30,617,840...30,626,395
G
MSMO1
methylsterol monooxygenase 1
affects expression
ISO
Imipramine affects the expression of MSMO1 mRNA
CTD
PMID:18355885
NCBI chr 4:165,327,669...165,343,164
Ensembl chr 4:165,327,667...165,343,164
G
NR0B2
nuclear receptor subfamily 0 group B member 2
increases expression
EXP
Imipramine results in increased expression of NR0B2 mRNA
CTD
PMID:15342952
NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975
G
NREP
neuronal regeneration related protein
affects expression
ISO
Imipramine affects the expression of NREP mRNA
CTD
PMID:18355885
NCBI chr 5:111,728,802...111,976,932
Ensembl chr 5:111,662,621...111,997,464
G
NTRK2
neurotrophic receptor tyrosine kinase 2
multiple interactions increases phosphorylation
ISO
Imipramine inhibits the reaction [NTRK2 protein binds to AP2M1 protein]; Imipramine promotes the reaction [NTRK2 protein binds to PLCG1 protein modified form]; Imipramine results in increased phosphorylation of and results in increased activity of NTRK2 protein Imipramine results in increased phosphorylation of NTRK2 protein
CTD
PMID:21666748 PMID:22396798 PMID:31631060
NCBI chr 9:84,668,522...85,027,054
Ensembl chr 9:84,668,375...85,095,751
G
NUPR1
nuclear protein 1, transcriptional regulator
increases expression
EXP
Imipramine results in increased expression of NUPR1 mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr16:28,532,708...28,538,974
Ensembl chr16:28,532,708...28,539,008
G
OAF
out at first homolog
affects expression
ISO
Imipramine affects the expression of OAF mRNA
CTD
PMID:18355885
NCBI chr11:120,211,032...120,230,334
Ensembl chr11:120,211,032...120,230,334
G
ORM2
orosomucoid 2
multiple interactions affects binding
EXP
Chlorpromazine inhibits the reaction [Imipramine binds to ORM2 protein alternative form]; Dipyridamole inhibits the reaction [Imipramine binds to ORM2 protein alternative form]; Disopyramide inhibits the reaction [Imipramine binds to ORM2 protein alternative form]; Lidocaine inhibits the reaction [Imipramine binds to ORM2 protein alternative form]; Methadone inhibits the reaction [Imipramine binds to ORM2 protein alternative form]; Progesterone inhibits the reaction [Imipramine binds to ORM2 protein alternative form]
CTD
PMID:8946472
NCBI chr 9:114,329,869...114,333,251
Ensembl chr 9:114,329,869...114,333,251
G
PARP1
poly(ADP-ribose) polymerase 1
increases cleavage
EXP
Imipramine results in increased cleavage of PARP1 protein
CTD
PMID:10487422
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
G
PC
pyruvate carboxylase
affects expression
ISO
Imipramine affects the expression of PC mRNA
CTD
PMID:18355885
NCBI chr11:66,848,420...66,958,383
Ensembl chr11:66,848,417...66,958,386
G
PECR
peroxisomal trans-2-enoyl-CoA reductase
affects expression
ISO
Imipramine affects the expression of PECR mRNA
CTD
PMID:18355885
NCBI chr 2:216,029,088...216,081,809
Ensembl chr 2:215,996,329...216,082,955
G
PLCG1
phospholipase C gamma 1
multiple interactions
ISO
Imipramine promotes the reaction [NTRK2 protein binds to PLCG1 protein modified form]
CTD
PMID:22396798
NCBI chr20:41,137,543...41,177,626
Ensembl chr20:41,136,960...41,196,801
G
POMC
proopiomelanocortin
multiple interactions
EXP
Imipramine inhibits the reaction [Buspirone results in increased expression of POMC protein]
CTD
PMID:19762159
NCBI chr 2:25,160,860...25,168,580
Ensembl chr 2:25,160,853...25,168,903
G
POR
cytochrome p450 oxidoreductase
affects expression
ISO
Imipramine affects the expression of POR mRNA
CTD
PMID:18355885
NCBI chr 7:75,915,155...75,986,855
Ensembl chr 7:75,899,200...75,986,855
G
PPP2CA
protein phosphatase 2 catalytic subunit alpha
multiple interactions
ISO
Imipramine inhibits the reaction [Ethanol results in increased activity of PPP2CA protein]
CTD
PMID:20224005
NCBI chr 5:134,194,332...134,226,073
Ensembl chr 5:134,194,035...134,226,073
G
RBL2
RB transcriptional corepressor like 2
affects expression
ISO
Imipramine affects the expression of RBL2 mRNA
CTD
PMID:18355885
NCBI chr16:53,434,471...53,491,648
Ensembl chr16:53,433,977...53,491,648
G
SCD
stearoyl-CoA desaturase
increases expression
EXP
Imipramine results in increased expression of SCD mRNA
CTD
PMID:16324787
NCBI chr10:100,347,233...100,364,826
Ensembl chr10:100,347,233...100,364,826
G
SERPINA3
serpin family A member 3
increases expression
EXP
Imipramine results in increased expression of SERPINA3 mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr14:94,612,391...94,624,053
Ensembl chr14:94,612,384...94,624,055
G
SERPINI1
serpin family I member 1
increases expression
ISO
Imipramine results in increased expression of SERPINI1 mRNA
CTD
PMID:16637596
NCBI chr 3:167,735,721...167,825,569
Ensembl chr 3:167,735,243...167,825,569
G
SH3GL3
SH3 domain containing GRB2 like 3, endophilin A3
affects expression
ISO
Imipramine affects the expression of SH3GL3 mRNA
CTD
PMID:18355885
NCBI chr15:83,447,341...83,633,820
Ensembl chr15:83,447,228...83,618,743
G
SHANK2
SH3 and multiple ankyrin repeat domains 2
decreases expression
EXP
Imipramine results in decreased expression of SHANK2 mRNA
CTD
PMID:34748853
NCBI chr11:70,467,854...71,253,228
Ensembl chr11:70,467,854...71,252,577
G
SLC22A1
solute carrier family 22 member 1
multiple interactions
EXP
Imipramine inhibits the reaction [SLC22A1 protein results in increased uptake of Metformin]; Imipramine inhibits the reaction [SLC22A1 protein results in increased uptake of Quercetin]; Imipramine inhibits the reaction [SLC22A1 protein results in increased uptake of Tetraethylammonium]
CTD
PMID:24947867 PMID:25106415
NCBI chr 6:160,121,815...160,158,718
Ensembl chr 6:160,121,815...160,158,718
G
SLC22A2
solute carrier family 22 member 2
multiple interactions
EXP
Imipramine inhibits the reaction [SLC22A2 protein polymorphism results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]; Imipramine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 6:160,216,755...160,258,821
Ensembl chr 6:160,171,061...160,277,638
G
SLC22A3
solute carrier family 22 member 3
multiple interactions
EXP
Imipramine inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium analog]; Imipramine inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]; Imipramine inhibits the reaction [SLC22A3 protein results in increased uptake of Metformin]
CTD
PMID:10966924 PMID:21697722
NCBI chr 6:160,348,378...160,452,577
Ensembl chr 6:160,348,378...160,452,577
G
SLC2A3
solute carrier family 2 member 3
decreases expression
EXP
Imipramine results in decreased expression of SLC2A3 mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr12:7,919,230...7,936,187
Ensembl chr12:7,919,230...8,019,007
G
SLC47A1
solute carrier family 47 member 1
decreases activity multiple interactions
EXP
Imipramine results in decreased activity of SLC47A1 protein Imipramine inhibits the reaction [SLC47A1 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:16928787 PMID:21599003
NCBI chr17:19,533,854...19,579,034
Ensembl chr17:19,495,385...19,579,034
G
SLC6A4
solute carrier family 6 member 4
decreases activity
ISO
Imipramine results in decreased activity of SLC6A4 protein
CTD
PMID:18561912
NCBI chr17:30,194,319...30,235,697
Ensembl chr17:30,194,319...30,236,002
G
SLC6A6
solute carrier family 6 member 6
affects expression
ISO
Imipramine affects the expression of SLC6A6 mRNA
CTD
PMID:18355885
NCBI chr 3:14,402,576...14,489,349
Ensembl chr 3:14,402,576...14,489,349
G
SLCO1A2
solute carrier organic anion transporter family member 1A2
affects expression
ISO
Imipramine affects the expression of SLCO1A4 mRNA
CTD
PMID:18355885
NCBI chr12:21,264,600...21,419,634
Ensembl chr12:21,264,600...21,419,594
G
SREBF1
sterol regulatory element binding transcription factor 1
multiple interactions
EXP
Imipramine results in increased cleavage of and results in increased activity of SREBF1 protein
CTD
PMID:16324787
NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002
G
SREBF2
sterol regulatory element binding transcription factor 2
multiple interactions
EXP
Imipramine results in increased cleavage of and results in increased activity of SREBF2 protein
CTD
PMID:16324787
NCBI chr22:41,833,105...41,907,305
Ensembl chr22:41,833,105...41,907,306
G
ST13
ST13 Hsp70 interacting protein
affects expression
ISO
Imipramine affects the expression of ST13 mRNA
CTD
PMID:18355885
NCBI chr22:40,824,535...40,856,639
Ensembl chr22:40,824,535...40,856,639
G
STBD1
starch binding domain 1
affects expression
ISO
Imipramine affects the expression of STBD1 mRNA
CTD
PMID:18355885
NCBI chr 4:76,306,733...76,311,130
Ensembl chr 4:76,306,733...76,311,130
G
STMN1
stathmin 1
affects expression
ISO
Imipramine affects the expression of STMN1 mRNA
CTD
PMID:18355885
NCBI chr 1:25,884,179...25,906,880
Ensembl chr 1:25,884,181...25,906,991
G
TAC1
tachykinin precursor 1
decreases expression
ISO
Imipramine results in decreased expression of TAC1 protein
CTD
PMID:8955926
NCBI chr 7:97,732,086...97,740,472
Ensembl chr 7:97,732,084...97,740,472
G
TAGLN
transgelin
decreases expression
EXP
Imipramine results in decreased expression of TAGLN mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr11:117,199,294...117,207,465
Ensembl chr11:117,199,370...117,207,464
G
TEX261
testis expressed 261
affects expression
ISO
Imipramine affects the expression of TEX261 mRNA
CTD
PMID:18355885
NCBI chr 2:70,985,942...70,994,873
Ensembl chr 2:70,968,325...70,994,873
G
TIMM10B
translocase of inner mitochondrial membrane 10B
affects expression
ISO
Imipramine affects the expression of TIMM10B mRNA
CTD
PMID:18355885
NCBI chr11:6,481,501...6,484,681
Ensembl chr11:6,481,501...6,484,681
G
TMPRSS2
transmembrane serine protease 2
increases expression
EXP
Imipramine results in increased expression of TMPRSS2 mRNA
CTD
PMID:32808185
NCBI chr21:41,464,305...41,508,158
Ensembl chr21:41,464,300...41,531,116
G
TNF
tumor necrosis factor
multiple interactions
ISO
Imipramine affects the reaction [caryophyllene inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of TNF protein]]; Imipramine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of TNF protein]; Imipramine inhibits the reaction [TNF protein results in increased abundance of N-palmitoylsphingosine] Imipramine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF protein]; Imipramine promotes the reaction [caryophyllene inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF protein]]
CTD
PMID:15946935 PMID:30529211 PMID:30620895
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
UBA52
ubiquitin A-52 residue ribosomal protein fusion product 1
affects expression
ISO
Imipramine affects the expression of UBA52 mRNA
CTD
PMID:18355885
NCBI chr19:18,563,766...18,577,550
Ensembl chr19:18,571,730...18,577,550
G
UGT1A1
UDP glucuronosyltransferase family 1 member A1
affects expression
ISO
Imipramine affects the expression of UGT1A1 mRNA
CTD
PMID:18355885
NCBI chr 2:233,760,270...233,773,300
Ensembl chr 2:233,760,270...233,773,300
G
UGT1A4
UDP glucuronosyltransferase family 1 member A4
affects metabolic processing multiple interactions increases glucuronidation
EXP
UGT1A4 protein affects the metabolism of Imipramine Finasteride inhibits the reaction [UGT1A4 protein results in increased glucuronidation of Imipramine] UGT1A4 protein results in increased glucuronidation of Imipramine; UGT1A4 protein SNP results in increased glucuronidation of Imipramine
CTD
PMID:9264550 PMID:14570768 PMID:15286053 PMID:15708967 PMID:25448279
NCBI chr 2:233,718,736...233,773,300
Ensembl chr 2:233,718,736...233,773,300
G
UGT2A1
UDP glucuronosyltransferase family 2 member A1 complex locus
affects expression
ISO
Imipramine affects the expression of UGT2A1 mRNA
CTD
PMID:18355885
NCBI chr 4:69,588,417...69,653,247
Ensembl chr 4:69,588,417...69,653,249
G
UGT2B17
UDP glucuronosyltransferase family 2 member B17
affects expression
ISO
Imipramine affects the expression of UGT2B1 mRNA
CTD
PMID:18355885
NCBI chr 4:68,537,173...68,576,322
Ensembl chr 4:68,537,173...68,576,413
G
WIPI1
WD repeat domain, phosphoinositide interacting 1
increases expression
EXP
Imipramine results in increased expression of WIPI1 mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr17:68,421,281...68,457,496
Ensembl chr17:68,420,948...68,457,513
G
AADAT
aminoadipate aminotransferase
affects expression
ISO
Clomipramine affects the expression of AADAT mRNA
CTD
PMID:18355885
NCBI chr 4:170,060,222...170,094,292
Ensembl chr 4:170,060,222...170,091,699
G
ABCB1
ATP binding cassette subfamily B member 1
affects expression
ISO
Clomipramine affects the expression of ABCB1 mRNA
CTD
PMID:18355885
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
G
ALDH1A1
aldehyde dehydrogenase 1 family member A1
affects expression
ISO
Clomipramine affects the expression of ALDH1A1 mRNA
CTD
PMID:18355885
NCBI chr 9:72,900,671...72,953,053
Ensembl chr 9:72,900,671...73,080,442
G
AP1S1
adaptor related protein complex 1 subunit sigma 1
decreases expression
EXP
Clomipramine results in decreased expression of AP1S1 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 7:101,154,476...101,161,276
Ensembl chr 7:101,154,456...101,161,596
G
APOA4
apolipoprotein A4
affects expression
ISO
Clomipramine affects the expression of APOA4 mRNA
CTD
PMID:18355885
NCBI chr11:116,820,700...116,823,304
Ensembl chr11:116,820,700...116,823,304
G
ASNS
asparagine synthetase (glutamine-hydrolyzing)
increases expression
EXP
Clomipramine results in increased expression of ASNS mRNA
CTD
PMID:17175557
NCBI chr 7:97,851,677...97,928,441
Ensembl chr 7:97,851,677...97,872,542
G
BHMT
betaine--homocysteine S-methyltransferase
affects expression
ISO
Clomipramine affects the expression of BHMT mRNA
CTD
PMID:18355885
NCBI chr 5:79,111,809...79,132,288
Ensembl chr 5:79,111,809...79,132,288
G
CASP3
caspase 3
multiple interactions increases activity
EXP ISO
Clomipramine results in increased cleavage of and results in increased activity of CASP3 protein; Palmitic Acid promotes the reaction [Clomipramine results in increased activity of CASP3 protein]
CTD
PMID:10487422 PMID:22700542 PMID:28482088
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CASP7
caspase 7
multiple interactions increases activity
EXP
Palmitic Acid promotes the reaction [Clomipramine results in increased activity of CASP7 protein]
CTD
PMID:22700542
NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907
G
CASP8
caspase 8
increases activity
ISO
Clomipramine results in increased activity of CASP8 protein
CTD
PMID:28482088
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
G
CASP9
caspase 9
increases activity
ISO
Clomipramine results in increased activity of CASP9 protein
CTD
PMID:28482088
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
G
CAT
catalase
decreases expression
EXP
Clomipramine results in decreased expression of CAT protein
CTD
PMID:1937386
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CDKN2C
cyclin dependent kinase inhibitor 2C
affects expression
ISO
Clomipramine affects the expression of CDKN2C mRNA
CTD
PMID:18355885
NCBI chr 1:50,968,706...50,974,634
Ensembl chr 1:50,960,745...50,974,634
G
CES2
carboxylesterase 2
affects expression
ISO
Clomipramine affects the expression of CES2 mRNA
CTD
PMID:18355885
NCBI chr16:66,934,471...66,945,096
Ensembl chr16:66,934,444...66,945,096
G
CMTM6
CKLF like MARVEL transmembrane domain containing 6
affects expression
ISO
Clomipramine affects the expression of CMTM6 mRNA
CTD
PMID:18355885
NCBI chr 3:32,481,312...32,502,852
Ensembl chr 3:32,481,312...32,502,852
G
CPPED1
calcineurin like phosphoesterase domain containing 1
affects expression
ISO
Clomipramine affects the expression of CPPED1 mRNA
CTD
PMID:18355885
NCBI chr16:12,659,799...12,803,887
Ensembl chr16:12,659,799...12,803,887
G
CREM
cAMP responsive element modulator
affects expression
ISO
Clomipramine affects the expression of CREM mRNA
CTD
PMID:18355885
NCBI chr10:35,126,846...35,212,958
Ensembl chr10:35,126,791...35,212,958
G
CYP1B1
cytochrome P450 family 1 subfamily B member 1
decreases activity
EXP
Clomipramine results in decreased activity of CYP1B1 protein
CTD
PMID:33814510
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
G
CYP2A13
cytochrome P450 family 2 subfamily A member 13
affects expression
ISO
Clomipramine affects the expression of CYP2A1 mRNA
CTD
PMID:18355885
NCBI chr19:41,088,451...41,096,195
Ensembl chr19:41,088,451...41,096,195
G
CYP4F12
cytochrome P450 family 4 subfamily F member 12
affects expression
ISO
Clomipramine affects the expression of CYP4F2 mRNA
CTD
PMID:18355885
NCBI chr19:15,673,087...15,697,174
Ensembl chr19:15,673,018...15,697,174
G
DCAF8
DDB1 and CUL4 associated factor 8
affects expression
ISO
Clomipramine affects the expression of DCAF8 mRNA
CTD
PMID:18355885
NCBI chr 1:160,215,720...160,262,549
Ensembl chr 1:160,215,715...160,262,549
G
DEPP1
DEPP autophagy regulator 1
increases expression
EXP
Clomipramine results in increased expression of DEPP1 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr10:44,976,128...44,978,809
Ensembl chr10:44,970,981...44,978,809
G
DRD2
dopamine receptor D2
increases expression
ISO
Clomipramine results in increased expression of DRD2 protein
CTD
PMID:20619828
NCBI chr11:113,409,605...113,475,398
Ensembl chr11:113,409,605...113,475,691
G
EIF4B
eukaryotic translation initiation factor 4B
affects expression
ISO
Clomipramine affects the expression of EIF4B mRNA
CTD
PMID:18355885
NCBI chr12:53,006,456...53,042,215
Ensembl chr12:53,006,282...53,042,215
G
EPHX1
epoxide hydrolase 1
affects expression
ISO
Clomipramine affects the expression of EPHX1 mRNA
CTD
PMID:18355885
NCBI chr 1:225,810,124...225,845,563
Ensembl chr 1:225,810,124...225,845,563
G
ERP29
endoplasmic reticulum protein 29
affects expression
ISO
Clomipramine affects the expression of ERP29 mRNA
CTD
PMID:18355885
NCBI chr12:112,013,426...112,023,449
Ensembl chr12:112,013,348...112,023,449
G
FABP1
fatty acid binding protein 1
increases expression
EXP
Clomipramine results in increased expression of FABP1 mRNA
CTD
PMID:15342952
NCBI chr 2:88,122,982...88,128,062
Ensembl chr 2:88,122,982...88,128,062
G
FH
fumarate hydratase
multiple interactions
ISO
Clomipramine results in increased activity of and results in increased secretion of FH protein
CTD
PMID:37217012
NCBI chr 1:241,497,603...241,519,755
Ensembl chr 1:241,497,511...241,519,799
G
FNDC4
fibronectin type III domain containing 4
increases expression decreases expression
EXP
Clomipramine results in increased expression of FNDC4 mRNA Clomipramine results in decreased expression of FNDC4 mRNA
CTD
PMID:17175557
NCBI chr 2:27,491,883...27,495,200
Ensembl chr 2:27,491,883...27,495,200
G
GCKR
glucokinase regulator
affects expression
ISO
Clomipramine affects the expression of GCKR mRNA
CTD
PMID:18355885
NCBI chr 2:27,496,839...27,523,684
Ensembl chr 2:27,496,839...27,523,684
G
GDPD3
glycerophosphodiester phosphodiesterase domain containing 3
increases expression
EXP
Clomipramine results in increased expression of GDPD3 mRNA
CTD
PMID:17175557
NCBI chr16:30,104,810...30,113,537
Ensembl chr16:30,104,810...30,113,537
G
GLS2
glutaminase 2
affects expression
ISO
Clomipramine affects the expression of GLS2 mRNA
CTD
PMID:18355885
NCBI chr12:56,470,952...56,488,161
Ensembl chr12:56,470,944...56,488,414
G
GOT2
glutamic-oxaloacetic transaminase 2
affects expression
ISO
Clomipramine affects the expression of GOT2 mRNA
CTD
PMID:18355885
NCBI chr16:58,707,131...58,734,316
Ensembl chr16:58,707,131...58,734,342
G
GPT
glutamic--pyruvic transaminase
increases export multiple interactions
ISO
Clomipramine results in increased export of GPT protein Clomipramine results in increased activity of and results in increased secretion of GPT protein
CTD
PMID:37217012
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
G
GRB14
growth factor receptor bound protein 14
affects expression
ISO
Clomipramine affects the expression of GRB14 mRNA
CTD
PMID:18355885
NCBI chr 2:164,492,417...164,621,482
Ensembl chr 2:164,492,417...164,621,482
G
GSTP1
glutathione S-transferase pi 1
decreases activity
EXP
Clomipramine results in decreased activity of GSTP1 protein
CTD
PMID:15094841
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
G
HAL
histidine ammonia-lyase
affects expression
ISO
Clomipramine affects the expression of HAL mRNA
CTD
PMID:18355885
NCBI chr12:95,972,662...95,996,344
Ensembl chr12:95,972,662...95,996,365
G
HMGB2
high mobility group box 2
affects expression
ISO
Clomipramine affects the expression of HMGB2 mRNA
CTD
PMID:18355885
NCBI chr 4:173,331,376...173,334,358
Ensembl chr 4:173,331,376...173,334,432
G
HMGCS1
3-hydroxy-3-methylglutaryl-CoA synthase 1
increases expression
EXP
Clomipramine results in increased expression of HMGCS1 mRNA
CTD
PMID:16324787
NCBI chr 5:43,287,470...43,313,412
Ensembl chr 5:43,287,470...43,313,512
G
HPN
hepsin
increases expression
EXP
Clomipramine results in increased expression of HPN mRNA
CTD
PMID:15342952
NCBI chr19:35,040,506...35,066,573
Ensembl chr19:35,040,506...35,066,573
G
HTR2C
5-hydroxytryptamine receptor 2C
affects binding increases expression
EXP ISO
Clomipramine binds to HTR2C protein Clomipramine results in increased expression of HTR2C protein
CTD
PMID:18083778 PMID:20619828
NCBI chr X:114,584,086...114,910,061
Ensembl chr X:114,584,078...114,910,061
G
IL1A
interleukin 1 alpha
multiple interactions
EXP
[IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to Clomipramine
CTD
PMID:19362101
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
G
IL33
interleukin 33
affects expression
ISO
Clomipramine affects the expression of IL33 mRNA
CTD
PMID:18355885
NCBI chr 9:6,215,149...6,257,983
Ensembl chr 9:6,215,786...6,257,983
G
IL6
interleukin 6
multiple interactions
EXP
[IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to Clomipramine
CTD
PMID:19362101
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
INHBE
inhibin subunit beta E
increases expression
EXP
Clomipramine results in increased expression of INHBE mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr12:57,455,307...57,458,025
Ensembl chr12:57,452,323...57,459,280
G
KCNH2
potassium voltage-gated channel subfamily H member 2
multiple interactions
EXP
Clomipramine inhibits the reaction [KCNH2 protein results in increased transport of Thallium]
CTD
PMID:21158687
NCBI chr 7:150,944,961...150,978,321
Ensembl chr 7:150,944,961...150,978,321
G
LOX
lysyl oxidase
affects expression
ISO
Clomipramine affects the expression of LOX mRNA
CTD
PMID:18355885
NCBI chr 5:122,063,195...122,078,259
Ensembl chr 5:122,063,195...122,078,413
G
LSS
lanosterol synthase
increases expression
EXP
Clomipramine results in increased expression of LSS mRNA
CTD
PMID:15342952
NCBI chr21:46,188,446...46,228,774
Ensembl chr21:46,188,141...46,228,824
G
MACROH2A1
macroH2A.1 histone
affects expression
ISO
Clomipramine affects the expression of MACROH2A1 mRNA
CTD
PMID:18355885
NCBI chr 5:135,334,381...135,399,887
Ensembl chr 5:135,334,381...135,399,914
G
MANBA
mannosidase beta
affects expression
ISO
Clomipramine affects the expression of MANBA mRNA
CTD
PMID:18355885
NCBI chr 4:102,630,770...102,760,968
Ensembl chr 4:102,630,770...102,760,994
G
MLX
MAX dimerization protein MLX
affects expression
ISO
Clomipramine affects the expression of MLX mRNA
CTD
PMID:18355885
NCBI chr17:42,567,100...42,573,203
Ensembl chr17:42,567,072...42,573,239
G
MRPS18B
mitochondrial ribosomal protein S18B
affects expression
ISO
Clomipramine affects the expression of MRPS18B mRNA
CTD
PMID:18355885
NCBI chr 6:30,617,840...30,626,392
Ensembl chr 6:30,617,840...30,626,395
G
MSMO1
methylsterol monooxygenase 1
affects expression
ISO
Clomipramine affects the expression of MSMO1 mRNA
CTD
PMID:18355885
NCBI chr 4:165,327,669...165,343,164
Ensembl chr 4:165,327,667...165,343,164
G
NR0B2
nuclear receptor subfamily 0 group B member 2
increases expression
EXP
Clomipramine results in increased expression of NR0B2 mRNA
CTD
PMID:17175557
NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975
G
NREP
neuronal regeneration related protein
affects expression
ISO
Clomipramine affects the expression of NREP mRNA
CTD
PMID:18355885
NCBI chr 5:111,728,802...111,976,932
Ensembl chr 5:111,662,621...111,997,464
G
NTRK2
neurotrophic receptor tyrosine kinase 2
increases phosphorylation
ISO
Clomipramine results in increased phosphorylation of NTRK2 protein
CTD
PMID:22396798
NCBI chr 9:84,668,522...85,027,054
Ensembl chr 9:84,668,375...85,095,751
G
NUPR1
nuclear protein 1, transcriptional regulator
increases expression
EXP
Clomipramine results in increased expression of NUPR1 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr16:28,532,708...28,538,974
Ensembl chr16:28,532,708...28,539,008
G
OAF
out at first homolog
affects expression
ISO
Clomipramine affects the expression of OAF mRNA
CTD
PMID:18355885
NCBI chr11:120,211,032...120,230,334
Ensembl chr11:120,211,032...120,230,334
G
PARP1
poly(ADP-ribose) polymerase 1
increases cleavage
EXP
Clomipramine results in increased cleavage of PARP1 protein
CTD
PMID:10487422
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
G
PC
pyruvate carboxylase
affects expression
ISO
Clomipramine affects the expression of PC mRNA
CTD
PMID:18355885
NCBI chr11:66,848,420...66,958,383
Ensembl chr11:66,848,417...66,958,386
G
PECR
peroxisomal trans-2-enoyl-CoA reductase
affects expression
ISO
Clomipramine affects the expression of PECR mRNA
CTD
PMID:18355885
NCBI chr 2:216,029,088...216,081,809
Ensembl chr 2:215,996,329...216,082,955
G
PHYH
phytanoyl-CoA 2-hydroxylase
increases expression
EXP
Clomipramine results in increased expression of PHYH mRNA
CTD
PMID:15342952
NCBI chr10:13,277,799...13,300,064
Ensembl chr10:13,277,796...13,302,412
G
POR
cytochrome p450 oxidoreductase
affects expression
ISO
Clomipramine affects the expression of POR mRNA
CTD
PMID:18355885
NCBI chr 7:75,915,155...75,986,855
Ensembl chr 7:75,899,200...75,986,855
G
PRL
prolactin
affects secretion increases expression multiple interactions increases secretion
EXP
Clomipramine affects the secretion of PRL protein Clomipramine results in increased expression of PRL protein SLC6A4 polymorphism inhibits the reaction [Clomipramine affects the secretion of PRL protein] Clomipramine results in increased secretion of PRL protein
CTD
PMID:3602989 PMID:7930386 PMID:17000009 PMID:19698552
NCBI chr 6:22,287,246...22,302,835
Ensembl chr 6:22,287,244...22,302,826
G
PROC
protein C, inactivator of coagulation factors Va and VIIIa
increases expression
EXP
Clomipramine results in increased expression of PROC protein
CTD
PMID:17891354
NCBI chr 2:127,418,427...127,429,242
Ensembl chr 2:127,418,427...127,429,242
G
RBL2
RB transcriptional corepressor like 2
affects expression
ISO
Clomipramine affects the expression of RBL2 mRNA
CTD
PMID:18355885
NCBI chr16:53,434,471...53,491,648
Ensembl chr16:53,433,977...53,491,648
G
SCD
stearoyl-CoA desaturase
increases expression
EXP
Clomipramine results in increased expression of SCD mRNA
CTD
PMID:16324787
NCBI chr10:100,347,233...100,364,826
Ensembl chr10:100,347,233...100,364,826
G
SERPINA3
serpin family A member 3
increases expression
EXP
Clomipramine results in increased expression of SERPINA3 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr14:94,612,391...94,624,053
Ensembl chr14:94,612,384...94,624,055
G
SH3GL3
SH3 domain containing GRB2 like 3, endophilin A3
affects expression
ISO
Clomipramine affects the expression of SH3GL3 mRNA
CTD
PMID:18355885
NCBI chr15:83,447,341...83,633,820
Ensembl chr15:83,447,228...83,618,743
G
SLC22A2
solute carrier family 22 member 2
multiple interactions
EXP
Clomipramine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 6:160,216,755...160,258,821
Ensembl chr 6:160,171,061...160,277,638
G
SLC2A3
solute carrier family 2 member 3
decreases expression
EXP
Clomipramine results in decreased expression of SLC2A3 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr12:7,919,230...7,936,187
Ensembl chr12:7,919,230...8,019,007
G
SLC6A4
solute carrier family 6 member 4
multiple interactions
EXP
Clomipramine binds to and results in decreased activity of SLC6A4 protein; SLC6A4 polymorphism inhibits the reaction [Clomipramine affects the secretion of PRL protein]
CTD
PMID:16272152 PMID:17000009
NCBI chr17:30,194,319...30,235,697
Ensembl chr17:30,194,319...30,236,002
G
SLC6A6
solute carrier family 6 member 6
affects expression
ISO
Clomipramine affects the expression of SLC6A6 mRNA
CTD
PMID:18355885
NCBI chr 3:14,402,576...14,489,349
Ensembl chr 3:14,402,576...14,489,349
G
SLCO1A2
solute carrier organic anion transporter family member 1A2
affects expression
ISO
Clomipramine affects the expression of SLCO1A4 mRNA
CTD
PMID:18355885
NCBI chr12:21,264,600...21,419,634
Ensembl chr12:21,264,600...21,419,594
G
SREBF1
sterol regulatory element binding transcription factor 1
multiple interactions
EXP
Clomipramine results in increased cleavage of and results in increased activity of SREBF1 protein
CTD
PMID:16324787
NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002
G
SREBF2
sterol regulatory element binding transcription factor 2
multiple interactions
EXP
Clomipramine results in increased cleavage of and results in increased activity of SREBF2 protein
CTD
PMID:16324787
NCBI chr22:41,833,105...41,907,305
Ensembl chr22:41,833,105...41,907,306
G
ST13
ST13 Hsp70 interacting protein
affects expression
ISO
Clomipramine affects the expression of ST13 mRNA
CTD
PMID:18355885
NCBI chr22:40,824,535...40,856,639
Ensembl chr22:40,824,535...40,856,639
G
STBD1
starch binding domain 1
affects expression
ISO
Clomipramine affects the expression of STBD1 mRNA
CTD
PMID:18355885
NCBI chr 4:76,306,733...76,311,130
Ensembl chr 4:76,306,733...76,311,130
G
STMN1
stathmin 1
affects expression
ISO
Clomipramine affects the expression of STMN1 mRNA
CTD
PMID:18355885
NCBI chr 1:25,884,179...25,906,880
Ensembl chr 1:25,884,181...25,906,991
G
TAC1
tachykinin precursor 1
decreases expression
ISO
Clomipramine results in decreased expression of TAC1 protein
CTD
PMID:8955926
NCBI chr 7:97,732,086...97,740,472
Ensembl chr 7:97,732,084...97,740,472
G
TAGLN
transgelin
decreases expression
EXP
Clomipramine results in decreased expression of TAGLN mRNA
CTD
PMID:17175557
NCBI chr11:117,199,294...117,207,465
Ensembl chr11:117,199,370...117,207,464
G
TEX261
testis expressed 261
affects expression
ISO
Clomipramine affects the expression of TEX261 mRNA
CTD
PMID:18355885
NCBI chr 2:70,985,942...70,994,873
Ensembl chr 2:70,968,325...70,994,873
G
THRA
thyroid hormone receptor alpha
multiple interactions
EXP
Clomipramine binds to and results in decreased activity of THRA protein
CTD
PMID:25752796
NCBI chr17:40,062,193...40,093,867
Ensembl chr17:40,058,290...40,093,867
G
TIMM10B
translocase of inner mitochondrial membrane 10B
affects expression
ISO
Clomipramine affects the expression of TIMM10B mRNA
CTD
PMID:18355885
NCBI chr11:6,481,501...6,484,681
Ensembl chr11:6,481,501...6,484,681
G
TNF
tumor necrosis factor
multiple interactions
EXP
[IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to Clomipramine
CTD
PMID:19362101
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
UBA52
ubiquitin A-52 residue ribosomal protein fusion product 1
affects expression
ISO
Clomipramine affects the expression of UBA52 mRNA
CTD
PMID:18355885
NCBI chr19:18,563,766...18,577,550
Ensembl chr19:18,571,730...18,577,550
G
UGT1A1
UDP glucuronosyltransferase family 1 member A1
affects expression
ISO
Clomipramine affects the expression of UGT1A1 mRNA
CTD
PMID:18355885
NCBI chr 2:233,760,270...233,773,300
Ensembl chr 2:233,760,270...233,773,300
G
UGT2A1
UDP glucuronosyltransferase family 2 member A1 complex locus
affects expression
ISO
Clomipramine affects the expression of UGT2A1 mRNA
CTD
PMID:18355885
NCBI chr 4:69,588,417...69,653,247
Ensembl chr 4:69,588,417...69,653,249
G
UGT2B17
UDP glucuronosyltransferase family 2 member B17
affects expression
ISO
Clomipramine affects the expression of UGT2B1 mRNA
CTD
PMID:18355885
NCBI chr 4:68,537,173...68,576,322
Ensembl chr 4:68,537,173...68,576,413
G
WIPI1
WD repeat domain, phosphoinositide interacting 1
increases expression
EXP
Clomipramine results in increased expression of WIPI1 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr17:68,421,281...68,457,496
Ensembl chr17:68,420,948...68,457,513
G
SLC22A2
solute carrier family 22 member 2
multiple interactions
EXP
Trimipramine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 6:160,216,755...160,258,821
Ensembl chr 6:160,171,061...160,277,638
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all